Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-27T10:02:41.393Z Has data issue: false hasContentIssue false
  • English
  • Français

Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection: II. Experiments with a ‘slow-killing’ strain

Published online by Cambridge University Press:  15 May 2009

L. H. Collier  and
Anne E. Mogg(Née Smith)
L. H. Collier
Affiliation:
Medical Research Council Trachoma Research Unit, Lister Institute of Preventive Medicine, London, S. W. 1
Anne E. Mogg(Née Smith)
Affiliation:
Medical Research Council Trachoma Research Unit, Lister Institute of Preventive Medicine, London, S. W. 1
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

After a single subcutaneous injection into baboons the MRC-4 strain of trachoma/inclusion conjunctivitis (TRIC) agent underwent limited multiplication at the injection site, but was then eliminated rapidly from the skin and regional lymph nodes. Forty-eight hours after a single intravenous injection, but not thereafter, it appeared in the peripheral lymph nodes and spleen. The single parenteral injections failed to immunize baboons against conjunctival challenge with the homologous strain. These findings contrasted with those previously reported for the more virulent mutant, MRC-4 f, which multiplied readily in the skin, lymph nodes and spleen, persisted in these tissues up to 3 weeks after injection, and conferred good immunity to conjunctival challenge with MRC-4. The difference in behaviour of MRC-4 and MRC-4 f might be accounted for, at least in part, by the use of a smaller inoculum of live MRC-4; but similar findings in guinea-pigs, reported elsewhere, suggest that the differences observed are real. In conjunction with previous work, the present study suggests that the immunogenicity of TRIC agent is closely related to the mass of antigen that can be administered to or propagated within the recipient.

We are grateful to Mr D. Venters for his able technical assistance.

Type
Research Article
Information
Journal of Hygiene , Volume 67 , Issue 3 , September 1969 , pp. 449 - 455
Copyright
Copyright © Cambridge University Press 1969

References

Blyth, W. A. (1967 a). Studies on TRIC organisms in tissues of normal and immune guinea pigs. Am. J. Ophthal. 63, 1153.Google Scholar
Blyth, W. A. (1967 b). Infection in guinea-pigs by organisms that cause trachoma and inclusion conjunctivitis. Br. J. exp. Path. 48, 142.Google Scholar
Collier, L. H. (1961). Experiments with trachoma vaccines: experimental system using inclusion blennorrhoea virus. Lancet i, 795.Google Scholar
Collier, L. H. & Blyth, W. A. (1966). Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods and preliminary tests with vaccines prepared in chick embryos and HeLa cells. J. Hyg., Camb. 64, 513.Google Scholar
Collier, L. H. & Smith, A. (1967). Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection. Am. J. Ophthal. 63, 1589.Google Scholar
Dulbecco, R. & Vogt, M. (1954). Plaque formation and isolation of pure lines with poliomyelitis viruses. J. exp. Med. 99, 167.CrossRefGoogle ScholarPubMed
Jones, B. R. (1961). TRIC virus infections in London. Trans. ophthal. Soc. U.K. 81, 367.Google Scholar
Jones, B. R. & Collier, L. H. (1962). Inoculation of man with inclusion blennorrhea virus. Ann. N.Y. Acad. Sci. 98, 212.CrossRefGoogle Scholar
Reeve, P. & Taverne, J. (1963). Observations on the growth of trachoma and inclusion blennorrhoea virus in embryonate eggs. J. Hyg., Camb. 61, 67.CrossRefGoogle Scholar
Taverne, J., Blyth, W. A. & Reeve, P. (1964). Toxicity of the agents of trachoma and inclusion conjunctivitis. J. gen. Microbiol. 37, 277.Google Scholar